Migrastatin analogues inhibit canine mammary cancer cell migration and invasion.
View/ Open
Date
2013-10-08Author
Lo Re, Daniele
Murphy, Paul V.
Metadata
Show full item recordUsage
This item's downloads: 341 (view details)
Cited 16 times in Scopus (view citations)
Recommended Citation
Majchrzak K, Lo Re D, Gajewska M, Bulkowska M, Homa A, PawŠowski K, Motyl T, Murphy PV, Król M (2013) 'Migrastatin analogues inhibit canine mammary cancer cell migration and invasion'. Plos One, 8 (10).
Published Version
Abstract
Cancer spread to other organs is the main cause of death of oncological patients. Migration of cancer cells from a primary tumour is the crucial step in the complex process of metastasis, therefore blocking this process is currently the main treatment strategy. Metastasis inhibitors derived from natural products, such as, migrastatin, are very promising anticancer agents. Thus, the aim of our study was to investigate the effect of six migrastatin analogues (MGSTA-1 to 6) on migration and invasion of canine mammary adenocarcinoma cell lines isolated from primary tumours and their metastases to the lungs. Canine mammary tumours constitute a valuable tool for studying multiple aspect of human cancer.
Description
Journal article